Evaluation of the efficacy of self monitoring blood glucose for gestational diabetes mellitus with onediagnostic reference point abnormality in new
Not Applicable
Not yet recruiting
- Conditions
- gestational diabetes mellitus
- Registration Number
- JPRN-UMIN000017236
- Lead Sponsor
- Osaka Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
multiple pregnancy requiring treatment with medication infected patients of the human immunodeficiency virus/ HBV/HCV. Overt diabetes
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method body weight HbA1c glycoalbumin plasma glucose Insrinogenic index Continuous glucose monitoring neonatal complications pregnancy complications
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie self-monitoring blood glucose efficacy in gestational diabetes mellitus with single diagnostic abnormality?
How does self-monitoring blood glucose compare to standard-of-care in managing one-point abnormality gestational diabetes mellitus?
What biomarkers predict response to self-monitoring blood glucose in gestational diabetes mellitus with isolated hyperglycemia?
Are there specific adverse events associated with self-monitoring blood glucose for gestational diabetes mellitus with single diagnostic abnormality?
What combination approaches enhance self-monitoring blood glucose outcomes in gestational diabetes mellitus with one-point abnormality?